Iron, autoimmunity, and thrombosis: Exploring sex-specific interactions

Iron is essential for oxygen delivery, energy production and several metabolic processes, but it also plays a crucial role in modulating immunity and coagulation. Impaired iron availability can contribute to both immune dysregulation and a prothrombotic state, resulting in tissue damage. This pathophysiological triad of iron deficiency, autoimmunity and hypercoagulability is particularly relevant in women, who are predisposed to lower iron stores due to hormonal and reproductive reasons, as well as to most autoimmune and some thrombotic conditions.This hypothesis-generating, narrative review article explores the intricate connections between iron status, immune response, and thrombosis, with a specific focus on sex-based differences. Here, we hypothesize that iron deficiency provides a common ground for the development of immune thrombotic conditions in predisposed women in response to environmental triggers. Evidence is discussed on how iron deficiency can specifically affect the function of different immune cells, resulting in unbalanced immune responses, and influence the synthesis of coagulation factors and platelets, increasing the risk of thrombotic events. The impact of gender-affirming hormone therapy on iron metabolism in transgender individuals is also addressed, emphasizing the importance of interpreting iron status based on hormonal exposure rather than sex assigned at birth.The aim is to provide a framework for testing the hypothesis that absolute iron deficiency and its compartmentalization into myeloid cells during inflammation can promote immune dysregulation and hypercoagulability. Understanding these complex interactions is essential for advancing precision medicine approaches in immune-mediated diseases. The manuscript advocates for considering sex-based differences and hormonal influences in the assessment and management of iron status, immune function, and thrombotic risk.